BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23006617)

  • 1. A novel exonic GHR splicing mutation (c.784G > C) in a patient with classical growth hormone insensitivity syndrome.
    Akıncı A; Rosenfeld RG; Hwa V
    Horm Res Paediatr; 2013; 79(1):32-8. PubMed ID: 23006617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
    Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
    Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel splice site mutation in the growth hormone receptor gene in Turkish patients with Laron-type dwarfism.
    Arman A; Ozon A; Isguven PS; Coker A; Peker I; Yordam N
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):47-58. PubMed ID: 18404972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I.
    Kang JH; Kim OS; Kim JH; Lee SK; Park YJ; Baik HW
    Int J Mol Med; 2012 Sep; 30(3):713-7. PubMed ID: 22751808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
    Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
    Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I.
    Besson A; Salemi S; Eblé A; Joncourt F; Gallati S; Jorge AA; Mullis PE
    Eur J Endocrinol; 2004 May; 150(5):635-42. PubMed ID: 15132718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
    Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
    Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation.
    Chatterjee S; Shapiro L; Rose SJ; Mushtaq T; Clayton PE; Ten SB; Bhangoo A; Kumbattae U; Dias R; Savage MO; Metherell LA; Storr HL
    Eur J Endocrinol; 2018 May; 178(5):481-489. PubMed ID: 29500309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity.
    David A; Miraki-Moud F; Shaw NJ; Savage MO; Clark AJ; Metherell LA
    Eur J Endocrinol; 2010 Jan; 162(1):37-42. PubMed ID: 19812236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
    Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel nonsense mutation (p.Y113X) in the human growth hormone receptor gene in a Brazilian patient with Laron syndrome].
    Diniz ET; Jorge AA; Arnhold IJ; Rosenbloom AL; Bandeira F
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1264-71. PubMed ID: 19169479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.
    Silbergeld A; Dastot F; Klinger B; Kanety H; Eshet R; Amselem S; Laron Z
    J Pediatr Endocrinol Metab; 1997; 10(3):265-74. PubMed ID: 9388817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical consequences of an intragenic growth hormone receptor (GHR) deletion in a large Chinese pedigree.
    Klammt J; Shen S; Kiess W; Kratzsch J; Stobbe H; Vogel M; Luo F; Pfäffle R
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):453-61. PubMed ID: 25196842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
    Rosenbloom AL
    Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome.
    Hui HN; Metherell LA; Ng KL; Savage MO; Camacho-Hübner C; Clark AJ
    J Pediatr Endocrinol Metab; 2005 Feb; 18(2):209-13. PubMed ID: 15751611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
    Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
    Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.